logo

2.13

2.13 (-0.64%)

As of Jun 14, 2022

Compass Therapeutics, Inc. [CMPX]

Source: 

Company Overview

We are a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases. Our scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth.

CountryUnited States
Headquartersbostonmassachusetts
Phone Number617-500-8099
Industry
manufacturing
CEOThomas J. Schuetz
Websitewww.clinicaltrials.gov